We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Herpes Remains Latent by Producing Self-inhibitory MicroRNA

By Biotechdaily staff writers
Posted on 15 Jul 2008
Molecular virologists have identified the mechanism used by the herpes simplex virus 1 (HSV1) to remain alive but latent in nerve cells until stimulated to renewed activity by excessive sunlight, fever, or other stresses.

During its latent phase, the virus does not replicate and practically the only molecular product that is being made is a type of RNA called latency-associated transcript RNA or LAT RNA. More...
While in the latent state the virus is not susceptible to antiviral treatment.
Writing in the July 2, 2008, online edition of the journal Nature, senior author Dr. Bryan Cullen, professor of molecular genetics and microbiology from Duke University (Durham, NC, USA), said, "It has always been a mystery what this product, LAT RNA, does. Usually viral RNAs exist to make proteins that are of use to the virus, but this LAT RNA is extremely unstable and does not make any proteins.”

Results presented in this study revealed that LAT functioned as a primary microRNA (miRNA) precursor that encoded four distinct miRNAs in HSV-1 infected cells. The investigators showed that one of the miRNAs, miR-H2-3p, was able to reduce expression of ICP0 protein--a viral immediate-early transcriptional activator that is important for productive HSV-1 replication--but did not significantly affect ICP0 messenger RNA levels. When faced with stress, the amount of ICP0 mRNA exceeded the amount of inhibitory miRNA, and the virus was stimulated to begin replication.

"Inactive virus is completely untouchable by any treatment we have. Unless you activate the virus, you cannot kill it,” said Dr. Cullen. "Once the virus is active, a patient would then take acyclovir, a drug that effectively kills replicating HSV1. In principle, you could activate and then kill all the virus in a patient. This would completely cure a person, and you would never get another cold sore.”


Related Links:
Duke University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.